Hironic Past Earnings Performance
Past criteria checks 5/6
Hironic has been growing earnings at an average annual rate of 24.7%, while the Medical Equipment industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 21.3% per year. Hironic's return on equity is 10%, and it has net margins of 21.5%.
Key information
24.7%
Earnings growth rate
24.6%
EPS growth rate
Medical Equipment Industry Growth | 22.7% |
Revenue growth rate | 21.3% |
Return on equity | 10.0% |
Net Margin | 21.5% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Hironic's (KOSDAQ:149980) Earnings Are Weaker Than They Seem
Mar 28Should You Rely On Hironic's (KOSDAQ:149980) Earnings Growth?
Nov 17Recent updates
Hironic Co., Ltd. (KOSDAQ:149980) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable
Jun 29If EPS Growth Is Important To You, Hironic (KOSDAQ:149980) Presents An Opportunity
Jun 12Hironic's (KOSDAQ:149980) Earnings Are Weaker Than They Seem
Mar 28The Price Is Right For Hironic Co., Ltd. (KOSDAQ:149980) Even After Diving 26%
Mar 19If You Like EPS Growth Then Check Out Hironic (KOSDAQ:149980) Before It's Too Late
Apr 05Does The Market Have A Low Tolerance For Hironic Co., Ltd.'s (KOSDAQ:149980) Mixed Fundamentals?
Mar 09A Look At Hironic's (KOSDAQ:149980) Share Price Returns
Feb 08Can Hironic (KOSDAQ:149980) Turn Things Around?
Jan 11Something To Consider Before Buying Hironic Co., Ltd. (KOSDAQ:149980) For The 1.0% Dividend
Dec 14Should You Rely On Hironic's (KOSDAQ:149980) Earnings Growth?
Nov 17Revenue & Expenses Breakdown
How Hironic makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 32,899 | 7,068 | 11,533 | 3,566 |
30 Jun 24 | 34,899 | 9,834 | 11,221 | 3,531 |
31 Mar 24 | 35,972 | 9,506 | 10,419 | 3,349 |
31 Dec 23 | 33,732 | 8,134 | 9,959 | 3,233 |
30 Sep 23 | 28,810 | 1,261 | 9,359 | 2,912 |
30 Jun 23 | 28,264 | 2,067 | 9,880 | 2,076 |
31 Mar 23 | 27,334 | 2,237 | 10,797 | 976 |
31 Dec 22 | 27,568 | 3,643 | 8,298 | 2,348 |
30 Sep 22 | 29,191 | 7,963 | 7,973 | 2,015 |
30 Jun 22 | 27,073 | 7,588 | 7,533 | 2,015 |
31 Mar 22 | 24,534 | 8,084 | 5,461 | 3,052 |
31 Dec 21 | 21,781 | 6,767 | 6,597 | 1,490 |
30 Sep 21 | 18,067 | 5,500 | 5,828 | 1,518 |
30 Jun 21 | 14,428 | 4,060 | 4,251 | 1,926 |
31 Mar 21 | 11,634 | 2,213 | 4,111 | 1,804 |
31 Dec 20 | 12,986 | 3,021 | 4,162 | 1,966 |
30 Sep 20 | 10,348 | 124 | 3,616 | 2,250 |
30 Jun 20 | 12,609 | 949 | 4,129 | 2,392 |
31 Mar 20 | 15,406 | 2,396 | 4,896 | 2,200 |
31 Dec 19 | 15,452 | 2,547 | 5,115 | 2,327 |
30 Sep 19 | 19,372 | 2,867 | 6,681 | 2,485 |
30 Jun 19 | 19,216 | 1,140 | 7,587 | 2,731 |
31 Mar 19 | 19,989 | 957 | 7,784 | 3,088 |
31 Dec 18 | 20,328 | -260 | 8,070 | 3,107 |
30 Sep 18 | 19,992 | 339 | 7,459 | 3,489 |
30 Jun 18 | 19,892 | 1,347 | 7,093 | 3,348 |
31 Mar 18 | 18,314 | 930 | 6,621 | 3,045 |
31 Dec 17 | 18,132 | 763 | 6,474 | 2,917 |
30 Sep 17 | 17,110 | 1,716 | 6,662 | 2,196 |
30 Jun 17 | 15,605 | 379 | 6,990 | 1,540 |
31 Mar 17 | 15,830 | 97 | 7,623 | 1,276 |
31 Dec 16 | 15,477 | 719 | 7,238 | 1,743 |
30 Sep 16 | 15,606 | -496 | 7,858 | 1,829 |
30 Jun 16 | 16,559 | 968 | 8,124 | 1,829 |
31 Mar 16 | 17,862 | 2,734 | 7,510 | 2,038 |
31 Dec 15 | 17,916 | 2,833 | 7,584 | 1,904 |
30 Sep 15 | 20,401 | 4,807 | 7,371 | 1,808 |
30 Jun 15 | 21,945 | 6,082 | 6,259 | 2,134 |
31 Mar 15 | 22,746 | 5,793 | 6,111 | 1,952 |
31 Dec 14 | 22,817 | 6,447 | 6,100 | 1,360 |
Quality Earnings: A149980 has high quality earnings.
Growing Profit Margin: A149980's current net profit margins (21.5%) are higher than last year (4.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A149980's earnings have grown significantly by 24.7% per year over the past 5 years.
Accelerating Growth: A149980's earnings growth over the past year (460.6%) exceeds its 5-year average (24.7% per year).
Earnings vs Industry: A149980 earnings growth over the past year (460.6%) exceeded the Medical Equipment industry -13.3%.
Return on Equity
High ROE: A149980's Return on Equity (10%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 12:36 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hironic Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Gwang Sik Park | Kyobo Securities Co., Ltd |
Sang-Yong Jeon | LS Securities Co., Ltd. |
HyunMok Cho | Shinhan Investment Corp. |